Efficacy and safety of golimumab induction for moderate-to-severe ulcerative colitis in the United Kingdom: results from the GO-COLITIS study

被引：0
|
作者：
Probert, C. [1 ]
Gaya, D. R. [2 ]
Hamlin, P. J. [3 ]
Irving, P. [4 ,5 ]
Sebastian, S. [6 ]
Gillespie, G. [7 ]
Tate, H. [7 ]
Wheeler, C. [7 ]
机构：
[1] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
[2] Glasgow Royal Infirm, Glasgow G4 0SF, Lanark, Scotland
[3] Leeds Teaching Hosp Trust, Leeds, W Yorkshire, England
[4] Guys Hosp, London SE1 9RT, England
[5] St Thomas Hosp, London, England
[6] Hull & East Yorkshire NHS Trust, Kingston Upon Hull, N Humberside, England
[7] MSD UK, Hoddesdon, England
来源：
JOURNAL OF CROHNS & COLITIS | 2016年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP049
引用
收藏
页码：S57 / S58
页数：2
相关论文
共 50 条
  • [11] Pharmacokinetics of golimumab in moderate to severe ulcerative colitis: the GO-KINETIC study
    Berends, Sophie E.
    Strik, Anne S.
    Jansen, Jeroen M.
    de Boer, Nanne K.
    van Egmond, Pleun S.
    Brandse, Johannan F.
    Mathot, Ron A.
    D'Haens, Geert R.
    Lowenberg, Mark
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (06) : 700 - 706
  • [12] Golimumab improves health-related quality of life of patients with moderate-to-severe ulcerative colitis: Results of the go-care study
    Saibeni, S.
    Bezzio, C.
    Bossa, F.
    Privitera, A. C.
    Marchi, S.
    Roselli, J.
    Mazzuoli, S.
    Geccherle, A.
    Soriano, A.
    Principi, M. B.
    Viola, A.
    Sarpi, L.
    Cappello, M.
    D'Inca, R.
    Mastronardi, M.
    Bodini, G.
    Guerra, M.
    Benedetti, A.
    Romano, M.
    Cicala, M.
    Di Sabatino, A.
    Scaldaferri, F.
    De Rosa, T.
    Giardino, A. M.
    Germano, V.
    Orlando, A.
    Armuzzi, A.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 (01) : 83 - 91
  • [13] Safety evaluation of ustekinumab for moderate-to-severe ulcerative colitis
    Miyoshi, Jun
    Matsuura, Minoru
    Hisamatsu, Tadakazu
    EXPERT OPINION ON DRUG SAFETY, 2022, 21 (01) : 1 - 8
  • [14] Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis
    Sandborn, William J.
    Feagan, Brian G.
    Marano, Colleen
    Zhang, Hongyan
    Strauss, Richard
    Johanns, Jewel
    Adedokun, Omoniyi J.
    Guzzo, Cynthia
    Colombel, Jean-Frederic
    Reinisch, Walter
    Gibson, Peter R.
    Collins, Judith
    Jarnerot, Gunnar
    Rutgeerts, Paul
    GASTROENTEROLOGY, 2014, 146 (01) : 96 - +
  • [15] Efficacy and Safety of Ivarmacitinib in Patients With Moderate-to-Severe, Active, Ulcerative Colitis: A Phase II Study
    Chen, Baili
    Zhong, Jie
    Li, Xiuling
    Pan, Feng
    Ding, Yijuan
    Zhang, Yan
    Chen, Hong
    Liu, Fei
    Zhang, Zhenyu
    Zhang, Ling
    Drozda, Rafal
    Oliinyk, Oleksandr
    Goh, Aik Han
    Chen, Xiang
    Sun, Xiang
    Rubin, David T.
    Sandborn, William J.
    Chen, Minhu
    GASTROENTEROLOGY, 2022, 163 (06) : 1555 - 1568
  • [16] Etrolizumab in moderate-to-severe ulcerative colitis
    Armuzzi, Alessandro
    Felice, Carla
    LANCET, 2014, 384 (9940): : 285 - 286
  • [17] Efficacy and safety of ustekinumab through Week 16 in patients with moderate-to-severe ulcerative colitis randomised to ustekinumab: results from the UNIFI induction trial
    Danese, S.
    Sands, B. E.
    O'Brien, C. D.
    Zhang, H.
    Johanns, J.
    Sloan, S.
    Izanec, J.
    Szapary, P.
    Marano, C.
    Leong, R. W.
    Rowbotham, D.
    Targan, S. R.
    Van Assche, G.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S61 - S62
  • [18] Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
    Sandborn, William J.
    Feagan, Brian G.
    Marano, Colleen
    Zhang, Hongyan
    Strauss, Richard
    Johanns, Jewel
    Adedokun, Omoniyi J.
    Guzzo, Cynthia
    Colombel, Jean-Frederic
    Reinisch, Walter
    Gibson, Peter R.
    Collins, Judith
    Jarnerot, Gunnar
    Hibi, Toshifumi
    Rutgeerts, Paul
    GASTROENTEROLOGY, 2014, 146 (01) : 85 - 95
  • [19] Efficacy and safety of tofacitinib in patients with moderate-to-severe ulcerative colitis: A real-world retrospective study
    Yoshimura, N.
    Okano, Soh
    Sako, Minako
    Takazoe, Masakazu
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S545 - S545
  • [20] Ozanimod Efficacy, Safety, and Histology in Patients with Moderate-to-Severe Ulcerative Colitis During Induction in the Phase 3 True North Study
    William, Sandborn
    Geert, D'Haens
    Doug, Wolf
    Stephen, Hanauer
    Igor, Jovanovic
    Subrata, Ghosh
    AnnKatrin, Petersen
    Steven, Hua
    Hwan, Lee Ji
    Lorna, Charles
    Keith, Usiskin
    Silvio, Danese
    Brian, Feagan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S6 - S7
12345